<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="province of China became the center of an outbreak of" exact="pneumonia" post="of unknown cause, which raised intense attention not only"/>
 <result pre="February 11, 2020. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20,200,211-sitrep-22-ncov.pdf. Accessed May27, 2020.,&quot; n.d.). COVID-19, a" exact="respiratory disease," post="has led to more than 22,140,472 confirmed cases and"/>
 <result pre="November 2002, when an infectious agent caused outbreaks of atypical" exact="pneumonia" post="in Guangdong Province, southern China, and Southeast Asia, North"/>
 <result pre="and countries. The disease caused by the virus was named" exact="severe acute respiratory syndrome" post="(SARS), for which a global alert was issued by"/>
 <result pre="The coronavirus was first identified as a cause of the" exact="common cold" post="in 1960 (Al-Osail and Al-Wazzah, 2017). Coronaviruses belong to"/>
 <result pre="Alphacoronaviruses and betacoronaviruses usually cause respiratory illness in humans and" exact="gastroenteritis" post="in animals. These two families include seven strains of"/>
 <result pre="pharyngitis, sinusitis, and other systemic symptoms such as occasional watery" exact="diarrhea" post="in humans of all ages. Based on current sequence"/>
 <result pre="receptor (Li et al., 2003; Raj et al., 2013). Murine" exact="hepatitis" post="virus (MHV), a β-coronavirus, uses carcinoembryonic antigen-related cell adhesion"/>
 <result pre="of aminopeptidase N (APN) (Godet et al., 1994), whereas transmissible" exact="gastroenteritis" post="virus (TGEV) requires recognition of APN in addition to"/>
 <result pre="to induce anti-tumor responses. GRP78, CD38, and GPC3 expression on" exact="cancer" post="cells have also been targeted for nanobody expression and"/>
 <result pre="been targeted for nanobody expression and purification, which provide useful" exact="cancer" post="cell markers and potential therapeutic markers (Aghamollaei et al.,"/>
 <result pre="from HIV (Forthal et al., 2001; Haynes et al., 2012)," exact="herpes simplex" post="virus (Kohl et al., 2000; Kohl and Loo, 1982,"/>
 <result pre="virus (Gunn et al., 2018; Saphire et al., 2018), and" exact="influenza" post="virus (Greenberg et al., 1977; Jegaskanda et al., 2014),"/>
 <result pre="approved a bivalent nanobody, caplacizumab, for treatment of patients with" exact="thrombotic thrombocytopenic purpura" post="(Hanlon and Metjian, 2020; Scully et al., 2019). Several"/>
 <result pre="bivalent nanobody, caplacizumab, for treatment of patients with thrombotic thrombocytopenic" exact="purpura" post="(Hanlon and Metjian, 2020; Scully et al., 2019). Several"/>
 <result pre="Nanobodies have also exhibited good antiviral effects against bovine viral" exact="diarrhea" post="virus (Li et al., 2017). Only limited studies have"/>
 <result pre="in the generation of vaccine candidates against SARS-CoV. Also, a" exact="rabies" post="virus-based vaccine expressing the SARS-CoV S protein has been"/>
 <result pre="Cadila Codon-optimised proteins of the new coronavirus, expressed by replicating" exact="measles" post="viral vector, will use reverse genetics to stimulate long-term"/>
 <result pre="for Vaccine Research The vaccine candidate consists of a replicating" exact="measles" post="viral vector Pre-Clinical (&quot;CEPI. CEPI collaborates with the Institut"/>
 <result pre="BiOCAD and IEM This viral vector vaccine based on attenuated" exact="influenza" post="virus backbone (intranasal) Pre-Clinical (&quot;BIOCAD, 2020. https://gmpnews.net/2020/03/biocad-begins-developing-covid-19-vaccine/. Accessed May21,"/>
 <result pre="The new intranasal vaccine is based on NasoVAX, the company’s" exact="influenza" post="vaccine candidate. Like NasoVAX, single intranasal dose would provide"/>
 <result pre="and Houser et al. (2017). References References AdedejiA.O.SeversonW.JonssonC.SinghK.WeissS.R.SarafianosS.G.Novel inhibitors of" exact="severe acute respiratory syndrome" post="coronavirus entry that act by three distinct mechanismsJ. Virol.8720138017802810.1128/JVI.00998-1323678171"/>
 <result pre="characterization of a novel nanobody for detection of GRP78 expressing" exact="cancer" post="cellsBiotechnol. Appl. Biochem.202010.1002/bab.1916 AJ VaccinesAJ Vaccines to Develop Vaccine"/>
 <result pre="is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from" exact="severe acute respiratory syndrome" post="coronavirus 2 with high potencyJ. Biol. Chem. jbc.RA120.013679.202010.1074/jbc.RA120.013679 CaoY.DengQ.DaiS.Remdesivir"/>
 <result pre="coronavirus 2 with high potencyJ. Biol. Chem. jbc.RA120.013679.202010.1074/jbc.RA120.013679 CaoY.DengQ.DaiS.Remdesivir for" exact="severe acute respiratory syndrome" post="coronavirus 2 causing COVID-19: an evaluation of the evidenceTravel"/>
 <result pre="March 19https://cepi.net/news_cepi/cepi-collaborates-withthe-2020institut-pasteur-in-a-consortium-to-develop-covid-19- vaccine/. Accessed May 21, 2020., n.d ChenZ.ZhangL.QinC.BaL.YiC.E.ZhangF.WeiQ.HeT.YuW.YuJ.GaoH.TuX.GettieA.FarzanM.YuenK.-Y.HoD.D.Recombinant modified" exact="vaccinia virus" post="Ankara expressing the spike glycoprotein of severe acute respiratory"/>
 <result pre="ChenZ.ZhangL.QinC.BaL.YiC.E.ZhangF.WeiQ.HeT.YuW.YuJ.GaoH.TuX.GettieA.FarzanM.YuenK.-Y.HoD.D.Recombinant modified vaccinia virus Ankara expressing the spike glycoprotein of" exact="severe acute respiratory syndrome" post="coronavirus induces protective neutralizing antibodies primarily targeting the receptor"/>
 <result pre="Microbes Infect.720186010.1038/s41426-018-0056-729618723 DuL.HeY.WangY.ZhangH.MaS.WongC.K.L.WuS.H.W.NgF.HuangJ.-D.YuenK.-Y.JiangS.ZhouY.ZhengB.-J.Recombinant adeno-associated virus expressing the receptor-binding domain of" exact="severe acute respiratory syndrome" post="coronavirus S protein elicits neutralizing antibodies: Implication for developing"/>
 <result pre="One82013e8158710.1371/journal.pone.0081587 DuanH.MaZ.XuL.ZhangA.LiZ.XiaoS.A novel intracellularly expressed NS5B-specific nanobody suppresses bovine viral" exact="diarrhea" post="virus replicationVet. Microbiol.240202010844910.1016/j.vetmic.2019.108449 DvekslerG.S.PensieroM.N.CardellichioC.B.WilliamsR.K.JiangG.S.HolmesK.V.DieffenbachC.W.Cloning of the mouse hepatitis virus"/>
 <result pre="bovine viral diarrhea virus replicationVet. Microbiol.240202010844910.1016/j.vetmic.2019.108449 DvekslerG.S.PensieroM.N.CardellichioC.B.WilliamsR.K.JiangG.S.HolmesK.V.DieffenbachC.W.Cloning of the mouse" exact="hepatitis" post="virus (MHV) receptor: expression in human and hamster cell"/>
 <result pre="May 21, 2020., n.d WuF.ZhaoS.YuB.ChenY.-M.WangW.SongZ.-G.HuY.TaoZ.-W.TianJ.-H.PeiY.-Y.YuanM.-L.ZhangY.-L.DaiF.-H.LiuY.WangQ.-M.ZhengJ.-J.XuL.HolmesE.C.ZhangY.-Z.A new coronavirus associated with human" exact="respiratory disease" post="in ChinaNature579202026526910.1038/s41586-020-2008-332015508 FaberM.LamirandeE.W.RobertsA.RiceA.B.KoprowskiH.DietzscholdB.SchnellM.J.A single immunization with a rhabdovirus-based vector"/>
 <result pre="in ChinaNature579202026526910.1038/s41586-020-2008-332015508 FaberM.LamirandeE.W.RobertsA.RiceA.B.KoprowskiH.DietzscholdB.SchnellM.J.A single immunization with a rhabdovirus-based vector expressing" exact="severe acute respiratory syndrome" post="coronavirus (SARS-CoV) S protein results in the production of"/>
 <result pre="GeoVax-Progresses-in-Coronavirus-COVID-19-Vaccine-Development-Program.html. Accessed May21, 2020., n.d GlowackaI.BertramS.MüllerM.A.AllenP.SoilleuxE.PfefferleS.SteffenI.TsegayeT.S.HeY.GnirssK.NiemeyerD.SchneiderH.DrostenC.PöhlmannS.Evidence that TMPRSS2 activates the" exact="severe acute respiratory syndrome" post="coronavirus spike protein for membrane fusion and reduces viral"/>
 <result pre="determinants are located within the same domain of the transmissible" exact="gastroenteritis" post="virus (coronavirus) spike proteinJ. Virol.681994800880167525985 GorlaniA.ForthalD.N.Antibody-dependent enhancement and the"/>
 <result pre="the risk of HIV infectionCurr. HIV Res.11201342142610.2174/1570162x11311666006224191936 GreenbergS.B.CriswellB.S.SixH.R.CouchR.B.Lymphocyte cytotoxicity to" exact="influenza" post="virus-infected cells. II. Requirement for antibody and non-T lymphocytesJ."/>
 <result pre="monoclonal antibody-mediated protection against ebola virusCell Host Microbe24201822123310.1016/j.chom.2018.07.009e530092199 HambachJ.RieckenK.CichutekS.SchützeK.AlbrechtB.PetryK.Targeting CD38-Expressing" exact="multiple myeloma" post="and burkitt lymphoma cells in vitro with nanobody-based chimeric"/>
 <result pre="ebola virusCell Host Microbe24201822123310.1016/j.chom.2018.07.009e530092199 HambachJ.RieckenK.CichutekS.SchützeK.AlbrechtB.PetryK.Targeting CD38-Expressing multiple myeloma and burkitt" exact="lymphoma" post="cells in vitro with nanobody-based chimeric antigen receptors (Nb-CARs)Cells9202010.3390/cells9020321"/>
 <result pre="antibodies in infected patientsJ. Virol.7820046134614210.1128/JVI.78.12.6134-6142.200415163706 HofmannH.PyrcK.HoekLvanderGeierM.BerkhoutB.PöhlmannS.Human coronavirus NL63 employs the" exact="severe acute respiratory syndrome" post="coronavirus receptor for cellular entryPNAS10220057988799310.1073/pnas.040946510215897467 HouserK.V.Enhanced inflammation in New"/>
 <result pre="and identification of linear B-cell epitopes and entry-blocking peptide of" exact="severe acute respiratory syndrome" post="(SARS)-associated coronavirus using synthetic overlapping peptide libraryJ. Comb. Chem.7200564865610.1021/cc050060716153058"/>
 <result pre="FcγR pathwayJ. Virol.852011105821059710.1128/JVI.00671-1121775467 JegaskandaS.ReadingP.C.KentS.J.Influenza-specific antibody-dependent cellular cytotoxicity: toward a universal" exact="influenza" post="vaccineJ. Immunol.193201446947510.4049/jimmunol.140043224994909 JiL.DongC.FanR.QiS.A high affinity nanobody against endothelin receptor"/>
 <result pre="the treatment of melanomaMol. Biol. Rep.4720202137214710.1007/s11033-020-05313-w32080807 JiangS.DuL.ShiZ.An emerging coronavirus causing" exact="pneumonia" post="outbreak in Wuhan, China: calling for developing therapeutic and"/>
 <result pre="coronavirus vaccines: immunogenicity and rapid translational developmentEBioMedicine202010274310.1016/j.ebiom.2020.10274332249203 KobingerG.P.FigueredoJ.M.RoweT.ZhiY.GaoG.SanmiguelJ.C.BellP.WivelN.A.ZitzowL.A.FliederD.B.HoganR.J.WilsonJ.M.Adenovirus-based vaccine prevents" exact="pneumonia" post="in ferrets challenged with the SARS coronavirus and stimulates"/>
 <result pre="robust immune responses in macaquesVaccine2520075220523110.1016/j.vaccine.2007.04.06517559989 KohlS.LooL.S.Protection of neonatal mice against" exact="herpes simplex" post="virus infection: probable in vivo antibody-dependent cellular cytotoxicityJ. Immunol.12919823703766282968"/>
 <result pre="Immunol.12919823703766282968 KohlS.CharleboisE.D.SigouroudiniaM.GoldbeckC.HartogK.SekulovichR.E.LangenbergA.G.M.BurkeR.L.Limited antibody-dependent cellular cytotoxicity antibody response induced by a" exact="herpes simplex" post="virus type 2 subunit vaccineJ. Infect. Dis.181200033533910.1086/31520810608784 KorberB.FischerW.M.GnanakaranS.YoonH.TheilerJ.AbfaltererW.HengartnerN.GiorgiE.E.BhattacharyaT.FoleyB.HastieK.M.ParkerM.D.PartridgeD.G.EvansC.M.FreemanT.M.de SilvaT.I.McDanalC.PerezL.G.TangH.Moon-WalkerA.WhelanS.P.LaBrancheC.C.SaphireE.O.MontefioriD.C.AngyalA.BrownR.L.CarrileroL.GreenL.R.GrovesD.C.JohnsonK.J.KeeleyA.J.LindseyB.B.ParsonsP.J.RazaM.Rowland-JonesS.SmithN.TuckerR.M.WangD.WylesM.D.Tracking"/>
 <result pre="the sialic acid binding activity with the enteropathogenicity of transmissible" exact="gastroenteritis" post="coronavirusJ. Virol.711997328532879060696 XiaL.TengQ.ChenQ.ZhangF.Preparation and characterization of Anti-GPC3 nanobody against"/>
 <result pre="confirmed cases: estimation and applicationAnn. Intern. Med.202010.7326/M20-0504 LaursenN.S.FriesenR.H.E.ZhuX.JongeneelenM.BloklandS.VermondJ.Universal protection against" exact="influenza" post="infection by a multidomain antibody to influenza hemagglutininScience362201859860210.1126/science.aaq062030385580 LedwithB.J.ManamS.TroiloP.J.BarnumA.B.PauleyC.J.GriffithsT.G.HarperL.B.SchockH.B.ZhangH.FarisJ.E.WayP.A.BeareC.M.BagdonW.J.NicholsW.W.Plasmid"/>
 <result pre="LaursenN.S.FriesenR.H.E.ZhuX.JongeneelenM.BloklandS.VermondJ.Universal protection against influenza infection by a multidomain antibody to" exact="influenza" post="hemagglutininScience362201859860210.1126/science.aaq062030385580 LedwithB.J.ManamS.TroiloP.J.BarnumA.B.PauleyC.J.GriffithsT.G.HarperL.B.SchockH.B.ZhangH.FarisJ.E.WayP.A.BeareC.M.BagdonW.J.NicholsW.W.Plasmid DNA vaccines: assay for integration into host"/>
 <result pre="into host genomic DNADev. Biol. (Basel)1042000334311713822 LeeN.HuiD.WuA.ChanP.CameronP.JoyntG.M.AhujaA.YungM.Y.LeungC.B.ToK.F.LuiS.F.SzetoC.C.ChungS.SungJ.J.Y.A major outbreak of" exact="severe acute respiratory syndrome" post="in Hong KongN. Engl. J. Med.34820031986199410.1056/NEJMoa03068512682352 LetkoM.MarziA.MunsterV.Functional assessment of"/>
 <result pre="coronavirusNature426200345045410.1038/nature0214514647384 LiT.HuangM.XiaoH.ZhangG.DingJ.WuP.ZhangH.ShengJ.ChenC.Selection and characterization of specific nanobody against bovine virus" exact="diarrhea" post="virus (BVDV) E2 proteinPLoS One122017e017846910.1371/journal.pone.0178469 LiS.ZhangW.JiangK.ShanH.ShiM.ChenB.HuaZ.Nanobody against the E7"/>
 <result pre="of coronavirusesAdvances in Virus Research2006Academic Press19329210.1016/S0065-3527(06)66005-3 MatsuyamaS.NagataN.ShiratoK.KawaseM.TakedaM.TaguchiF.Efficient activation of the" exact="severe acute respiratory syndrome" post="coronavirus spike protein by the transmembrane protease TMPRSS2J. Virol.842010126581266410.1128/JVI.01542-1020926566"/>
 <result pre="SARS-CoV-2 enhances spike protein cleavage by TMPRSSbioRxiv2020202010.1101/2020.02.08.92600602.08.926006 MeyerK.Ait-GoughoulteM.KeckZ.-Y.FoungS.RayR.Antibody-dependent enhancement of" exact="hepatitis" post="C virus infectionJ. Virol.8220082140214910.1128/JVI.01867-0718094180 MIGAL’s Coronavirus Vaccine Project:https://www.migal.org.il/en/node/7010. Accessed"/>
 <result pre="2020., n.d. SchriewerL.SchützeK.PetryK.HambachJ.FumeyW.KoenigsdorfJ.Nanobody-based CD38-specific heavy chain antibodies induce killing of" exact="multiple myeloma" post="and other hematological malignanciesTheranostics1020202645265810.7150/thno.3853332194826 SchultzeB.GrossH.J.BrossmerR.HerrlerG.The S protein of bovine"/>
 <result pre="2020., n.d ShullaA.Heald-SargentT.SubramanyaG.ZhaoJ.PerlmanS.GallagherT.A transmembrane serine protease is linked to the" exact="severe acute respiratory syndrome" post="coronavirus receptor and activates virus entryJ. Virol.85201187388210.1128/JVI.02062-1021068237 SiuY.L.TeohK.T.LoJ.ChanC.M.KienF.EscriouN.TsaoS.W.NichollsJ.M.AltmeyerR.PeirisJ.S.M.BruzzoneR.NalB.The M,"/>
 <result pre="genetic recombination, and pathogenesis of coronavirusesTrends Microbiol.24201649050210.1016/j.tim.2016.03.00327012512 SuiJ.LiW.MurakamiA.TaminA.MatthewsL.J.WongS.K.MooreM.J.TallaricoA.S.C.OlurindeM.ChoeH.AndersonL.J.BelliniW.J.FarzanM.MarascoW.A.Potent neutralization of" exact="severe acute respiratory syndrome" post="(SARS) coronavirus by a human mAb to S1 protein"/>
 <result pre="Marchhttp://www.takisbiotech.it/index.php/en/news/209-rome-17-march-2020-takis-a-biotech-company-in-castel-romano-rome-announces-that-it-is-ready-to-test-its-covid-19-vaccine-on-pre-clinical-models2020Accessed on May 21, 2020., n.d TarrA.W.LafayeP.MeredithL.Damier-PiolleL.UrbanowiczR.A.MeolaA.JestinJ.-L.BrownR.J.P.McKeatingJ.A.ReyF.A.BallJ.K.KreyT.An alpaca nanobody inhibits" exact="hepatitis" post="C virus entry and cell-to-cell transmissionHepatology58201393293910.1002/hep.2643023553604 ter MeulenJ.BakkerA.B.H.van den"/>
 <result pre="neutralization of SARS coronavirusNat. Med.10200487187510.1038/nm108015247913 TsangK.W.HoP.L.OoiG.C.YeeW.K.WangT.Chan-YeungM.LamW.K.SetoW.H.YamL.Y.CheungT.M.WongP.C.LamB.IpM.S.ChanJ.YuenK.Y.LaiK.N.A cluster of cases of" exact="severe acute respiratory syndrome" post="in Hong KongN. Engl. J. Med.34820031977198510.1056/NEJMoa03066612671062 TseL.V.MeganckR.M.GrahamR.L.BaricR.S.The current and"/>
 <result pre="21, 2020., n.d van DoremalenN.LambeT.SpencerA.Belij-RammerstorferS.PurushothamJ.N.PortJ.R.AvanzatoV.BushmakerT.FlaxmanA.UlaszewskaM.FeldmannF.AllenE.R.SharpeH.SchulzJ.HolbrookM.OkumuraA.Meade-WhiteK.Pérez-PérezL.BissettC.GilbrideC.WilliamsonB.N.RosenkeR.LongD.IshwarbhaiA.KailathR.RoseL.MorrisS.PowersC.LovaglioJ.HanleyP.W.ScottD.SaturdayG.de WitE.GilbertS.C.MunsterV.J.ChAdOx1 nCoV-19 vaccination prevents SARS-CoV-2" exact="pneumonia" post="in rhesus macaques (preprint)Microbiology.202010.1101/2020.05.13.093195 VaxartVaxart Announces Additional Positive Pre-clinical"/>
 <result pre="non-neutralising antibodies at early stages of infectionRetrovirology820111610.1186/1742-4690-8-1621401915 WilliamsR.K.JiangG.S.HolmesK.V.Receptor for mouse" exact="hepatitis" post="virus is a member of the carcinoembryonic antigen family"/>
 <result pre="protective efficacy against MERS-CoVJ. Virol.92201810.1128/JVI.00837-18e00837-18, /jvi/92/18/e00837-18.atom ZhongN.S.ZhengB.J.LiY.M.PoonL.L.M.XieZ.H.ChanK.H.LiP.H.TanS.Y.ChangQ.XieJ.P.LiuX.Q.XuJ.LiD.X.YuenK.Y.PeirisJ.S.M.GuanY.Epidemiology and cause of" exact="severe acute respiratory syndrome" post="(SARS) in Guangdong, People’s Republic of China, in February,"/>
 <result pre="in Guangdong, People’s Republic of China, in February, 2003Lancet36220031353135810.1016/S0140-6736(03)14630-214585636 ZhouP.YangX.-L.WangX.-G.HuB.ZhangL.ZhangW.A" exact="pneumonia" post="outbreak associated with a new coronavirus of probable bat"/>
</results>
